George Washington University Sponsors Immunology Research at ONPRC
Trusted by teams at
Description
George Washington University funds interdisciplinary research at ONPRC on SIV elite controllers and dengue therapy, with projects concluding between 2026 and 2029.
Contract Details
Contract Amount
$2,878,144 (SIV Elite Controller Cohort genetic analysis), $1,408,802 (Antibody treatment for dengue fever), $105,357 (Maternal-fetal interface project)
Vendor
GEORGE WASHINGTON UNIVERSITY
Agency
Oregon Health & Science University, OR
Contract Type
RESEARCH_GRANT
Document Date
January 22, 2026
Contract Term
Project end dates: 08/31/26, 04/20/26, 05/31/29
Renewal Date
2029-05-31
Renewal Info
Grants specified per project timeline; renewals subject to new funding cycles.
More from GEORGE WASHINGTON UNIVERSITY
More from Oregon Health & Science University
Oregon Health & Science University Board of Directors Public Meeting Agenda Packet 2026-06-17
Oregon Health & Science University Board of Directors Resolution 2026-02-01
OHSU Public Meeting of Finance & Audit Agenda Packet January 2026
OHSU Public Meeting of Finance & Audit Agenda Packet January 2026
OHSU Public Meeting of Finance & Audit Agenda Packet January 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.